Get all your news in one place.
100's of premium titles.
One app.
Start reading
The Guardian - UK
The Guardian - UK
Politics
Andrew Gregory Health editor

Two breast cancer drugs available on NHS in England after U-turn

A consultant studying a mammogram.
A consultant studying a mammogram. Photograph: Rui Vieira/PA

Thousands of breast cancer patients in England are to benefit from two new drugs available on the NHS following a U-turn by the health watchdog.

About 3,500 women a year will benefit from life-extending drugs Alpelisib and Trodelvy, which have now been given the green light despite being rejected earlier this year by the National Institute for Health and Care Excellence (Nice).

Sign up to read this article
Read news from 100's of titles, curated specifically for you.
Already a member? Sign in here
Related Stories
Top stories on inkl right now
One subscription that gives you access to news from hundreds of sites
Already a member? Sign in here
Our Picks
Fourteen days free
Download the app
One app. One membership.
100+ trusted global sources.